KottilWRammohanMD

Neurology • Miami, FL

Physician

Join to view full profile

Dr. Rammohan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rammohan's full profile

Already have an account?

Office
1120 NW 14th Street
Suite 1322
Miami, FL 33136
Phone+1 305-243-4655

Fax+1 305-243-2777

Education & Training

Ohio State University HospitalResidency, Neurology, 1975 - 1976
Ohio State University HospitalResidency, Internal Medicine, 1974 - 1975
Ohio State University HospitalResidency, Neurology, 1972 - 1974
Ohio State University HospitalResidency, Internal Medicine, 1972 - 1972
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1970 - 1971
Madras Medical CollegeClass of 1969

Certifications & Licensure

IL State Medical License 1973 - Present
FL State Medical License 1973 - 2026
OH State Medical License 1976 - 2026
MD State Medical License 1977 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
Completed
Phase 2
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Terminated
Phase 3
Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach Start of enrollment: 2018 Mar 23
Completed
Phase 1
Histaminergic Basis of Fatigue in Multiple Sclerosis Start of enrollment: 2022 Jan 01
Withdrawn
Phase 2
Join now to see all

Publications & Presentations

PubMed

Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for th...
Gavin Giovannoni, Alexey Boyko, Jorge Correale, Gilles Edan, Mark S Freedman
Multiple Sclerosis. 2024-12-17
6 citations
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment.
Silvia R Delgado, Simon Faissner, Ralf A Linker, Kottil Rammohan
Journal of Neurology. 2024-04-01
5 citations
Identification and management of subclinical disease activity in early multiple sclerosis: a review.
Daniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, Ahmed Z Obeidat
Journal of Neurology. 2024-04-01

Grant Support

Clinical Trial: Treatment Of Inadequate CD4+ Lymphocyte Recovery In RrmsNational Center For Research Resources2008
Clinical Trial: Study To Evaluate The Safety And Efficacy Of Oral CladribineNational Center For Research Resources2008
Clinical Trial: Safety, Tolerability, And Effects Of Two Doses Of Cdp323 In MSNational Center For Research Resources2008
Clinical Trial: Safety Tolerablility, And Efficacy Of Betaseron?/BetaferonNational Center For Research Resources2008
Clinical Trial: Safety And Tolerability Of Betaseron In Patients With RrmsNational Center For Research Resources2008
Clinical Trial: Rituximab In Adults With Primary Progressive Multiple SclerosisNational Center For Research Resources2008
Clinical Trial: Interferon Beta-La And Glatiramer Acetate To Either Agent AloneNational Center For Research Resources2008
Clinical Trial: Glatiramer Acetate In RrmsNational Center For Research Resources2008
Study To Evaluate The Safety And Efficacy Of Oral CladribineNational Center For Research Resources2007
Safety And Tolerability Of Betaseron In Patients With RrmsNational Center For Research Resources2007
Rituximab In Adults With Primary Progressive Multiple SclerosisNational Center For Research Resources2007
Rebif With Copaxone Administered To Relapsing Remitting Multiple Sclerosis PTSNational Center For Research Resources2007
Interferon Beta-La And Glatiramer Acetate To Either Agent AloneNational Center For Research Resources2007
Glatiramer Acetate In RrmsNational Center For Research Resources2007
Evaluate Efficacy Of Avonex &Secondary Multiple SclerosisNational Center For Research Resources1999–2001
Safety And Efficacy Of Two Doses Of BetaseronNational Center For Research Resources1998–2001
Avonex In Treating High Development Of Multiple SclerosisNational Center For Research Resources1998–2001
Treatment Of Fatigue In Multiple Sclerosis With Provigil (MODAFINIL)National Center For Research Resources2000
Safety And Efficacy Of Two Doses Of Betaseron In Secondary Multiple SclerosisNational Center For Research Resources1997